To commemorate the introduction of the generic version of Lipitor, a bipartisan group of three Senators has sent letters to Lipitor's manufacturer, Pfizer, three major PBMs, and two insurers "after a news report alleged Pfizer agreed to provide discounts to
pharmaceutical benefit management companies (PBMs) and insurance
companies if the PBMs and the insurers would block prescriptions for